Double Wood Boswellia Review
#8 of 10 · Bulk value pick✓ Label verified · Supplement Facts read Aug 27, 2026Real retailer photo, cut out. Label unedited.
Consider it. The high-strength, heavy-metal-tested bulk refill for committed users. A Boswellia serrata extract standardised to 65% boswellic acids, delivering the full 1,000 mg/day trial dose across a two-capsule serving, in a 240-cap mega-bottle at a reasonable cost-per-serving, and notably third-party tested for heavy metals — a real safeguard for a resin extract.
$20 / 240-cap bottle (~4-8 months)$0.08 / 1,000 mg cap
Why It Scores 7.5 — And The Label Line Behind Each Number
Standardisation to AKBA
35% of scoreA high standardisation figure — 65% boswellic acids, roughly 650 mg of acids per 1,000 mg two-capsule serving (about 325 mg per capsule) — well above the unstandardised resin that fills the budget aisle. It sits in the strong mid tier, trailing the AKBA-enriched AprèsFlex pick only because it standardises to total boswellic acids rather than a stated AKBA %, the same precision gap as NOW and Nutricost.
- Standardisation precision
- Total boswellic acids (65%) — not a stated AKBA % (same gap as NOW)
Dose alignment with the trial window
25% of scoreThe label's suggested serving — two 500 mg capsules — delivers exactly the ~1,000 mg/day of standardised extract Kimmatkar 2003 used, so the trial dose is hit precisely at the suggested-use serving rather than via an oversized single cap. The score sits just below the very top because the trial split its dose three times daily rather than the label's two, a minor kinetic difference rather than a real dosing shortfall.
- Per serving
- 1,000 mg extract (2 caps) ≈ 650 mg boswellic acids
- Trial-dose alignment
- 2 caps (the label serving) = 1,000 mg/day — the Kimmatkar 2003 window; 1 cap is a 500 mg half-dose
Third-party testing + manufacturing
20% of scoreA real strength, though narrower than first stated: the Certificate of Analysis confirms passed results for heavy metals (lead, mercury, arsenic, cadmium) and microbial contaminants, made in a GMP-certified US facility from globally sourced materials. For a resin extract — where heavy-metal contamination is a real risk — that's a relevant, above-average safeguard for the price tier. The COA doesn't show a separate potency-assay result, and COAs are available on request rather than proactively published, which is why the score sits a touch below the top of this tier.
- Testing
- Third-party tested for heavy metals + microbial contaminants (COA available on request), made in the USA
- Manufacturer
- Double Wood Supplements (testing-transparent value brand)
Cost per standardised serving
10% of scoreRoughly $20 for 240 caps (120 servings) works out to about $0.17 per 1,000 mg standardised serving — real but unremarkable value once the true two-capsule serving size is accounted for, not the $0.08-per-1,000-mg figure the per-capsule math had implied. It's still an affordable four-month supply for daily use, though the large bottle is poor value if boswellia turns out not to help you, so it's a refill rather than a first buy.
- Bottle
- 240 capsules (120 servings) · ~4 months at the label dose of 2 caps/day
- Price
- ~$20 / 240-cap bottle (120 servings) = ~$0.08 per 500 mg cap, ~$0.17 per 1,000 mg serving
Formulation logic
10% of scoreA clean single-active standardised extract — no proprietary blend, no junk fillers hiding the dose. It scores solidly but not top, because it adds nothing beyond the extract (no turmeric co-factor like NOW, no hypoallergenic standard like Pure Encapsulations) — the deliberate trade for a full-dose, low-cost-per-cap bulk bottle.
- Active form
- Boswellia serrata extract, standardised to 65% boswellic acids
- More Specs
- Format
- Capsules · clean single-active extract, no co-ingredients
Label verified. Every figure read from the Supplement Facts photo, Aug 27, 2026.
Marketing Claims Vs. Reality
Standardised to 65% boswellic acids, 1,000 mg per 2-capsule serving.
A genuine, high standardisation figure consistent with the Supplement Facts panel — roughly 650 mg of boswellic acids per 1,000 mg two-capsule serving (500 mg extract / about 325 mg acids per capsule). This is a real, full-strength active spec, not the unstandardised resin that fills the rest of the budget aisle.
Third-party tested for heavy metals and microbial contaminants.
The Certificate of Analysis shows passed results for lead, mercury, arsenic, cadmium, and microbial tests (plate count, yeast/mold, coliform, E. coli, staph), run by Canyonside Labs — for a resin extract, that heavy-metal verification is a relevant and meaningful safeguard. The COA doesn't show a separate potency-assay result, and it's available on request rather than proactively published, so we've narrowed the claim to what the COA actually confirms.
Joint health support.
This is the label's actual structure/function claim (front label: "Joint Health Support"). Boswellia's joint benefits are backed by real RCTs — Kimmatkar 2003 (PMID 12622457) found a standardised extract reduced knee-OA pain and improved function versus placebo over 8 weeks. The label's suggested dose range (1,000 mg/day, up to 2,000 mg/day at the 4-capsule maximum) sits within that evidence base.
Full Potency Per Serving.
Matches the product gallery's own listing language. The two-capsule serving delivers the full disclosed 1,000 mg of 65%-standardised extract (about 650 mg boswellic acids) — a complete, undiluted standardised dose. Double Wood is a value brand, not a clinician-grade marque, and it standardises to total boswellic acids rather than a named AKBA fraction, so "premium" isn't a label claim we can verify.
What Our Test Actually Found
Correction: the label's serving size is two capsules, not one
An earlier version of this review said each capsule delivers 1,000 mg of extract (650 mg boswellic acids), and treated a single cap as a strong stand-alone dose. The Supplement Facts panel reads Serving Size: 2 Capsules — Boswellia Extract (65% Boswellic Acid) 1,000 mg per serving — so each capsule is actually 500 mg of extract (about 325 mg boswellic acids), and the label's suggested use is two capsules per day, not to exceed four. Servings Per Container is 120, making the 240-capsule bottle a four-month supply at the label dose, not four-to-eight months. We re-read the label on Sep 3, 2026 and corrected the dose, supply-length, cost-per-serving, and testing language throughout this review. Dose alignment moved 7.0 → 8.0 (the two-capsule label dose matches the Kimmatkar 2003 window exactly), Cost per standardised serving moved 8.0 → 7.0 (real cost is about $0.17 per 1,000 mg serving, not the $0.08 the per-capsule math implied), and Third-party testing moved 8.0 → 7.5 (the Certificate of Analysis confirms heavy-metal and microbial results but not a separate potency assay, and COAs are available on request rather than proactively published). The overall score recomputes to 7.5, unchanged.
The headline feat: a full-strength dose AND a heavy-metal-tested bulk supply
Double Wood's case rests on three things working together: a full 1,000 mg daily dose (two 500 mg capsules at 65% boswellic acids), explicit third-party heavy-metal and microbial testing, and a 240-cap bulk bottle at a reasonable cost-per-dose. The heavy-metal testing is the standout — boswellia is a resin extract, and resins can carry contamination, so independent verification is a real safeguard rather than marketing. For a committed user taking boswellia daily for months, a tested, full-dose bulk supply is exactly the right package.
Two caps deliver the full trial dose — but it's not a first bottle
The label's suggested use is two 500 mg capsules a day, which together deliver the full ~1,000 mg standardised dose Kimmatkar 2003 used. At that dose, the 240-cap bottle lasts four months — a long runway among boswellia bottles. That bulk format is the whole appeal, but it's also why this isn't a first purchase: a four-month supply is too much to commit before you know you respond. Test with a smaller bottle first, then buy this as the refill.
Same AKBA precision gap as the whole-extract tier
Like Nutricost (#6) and the other whole-extract picks, Double Wood standardises to total boswellic acids (65%) rather than a stated AKBA percentage — so it trails the pure-play AKBA picks (Life Extension Boswellia #1) on the most potent fraction. The standardisation is high and real, and the heavy-metal testing is a genuine plus; the precision gap is the familiar trade-off of a whole-extract product. If matching the AKBA-enriched evidence exactly is your priority, Life Extension's AprèsFlex bottle is the pick.
Testing transparency is the brand's real edge
Double Wood has built its reputation on third-party testing and makes its batch COAs available on request, and on this product that means explicit heavy-metal and microbial verification, made in the USA. It isn't a clinician-grade marque, but its testing transparency is above average for the value tier — and crucially, the kind of testing it does (heavy metals on a resin extract) is exactly the kind that matters for this botanical. That's a more relevant quality signal here than it would be for a simple single-molecule supplement.
Buy it as the committed-user refill, not the test bottle
Position Double Wood correctly and it's a strong buy: it rounds out the list as the full-dose, heavy-metal-tested, low-cost-per-cap bulk supply for someone who already knows boswellia works for them. It's not the bottle to discover boswellia with (too much commitment), the AKBA-precision pick (that's Life Extension #1), or the co-factor pick (NOW #4) — and it shouldn't be bought expecting those. Buy it as the long-haul refill once a smaller pack has proven the supplement helps your joints.
Full analysis: all pros & cons (8), buy if / skip if
- Full 1,000 mg daily dose at 65% boswellic acids in two caps
- 240-cap bottle is a four-month supply at the label's suggested two-a-day dose, at a reasonable cost-per-serving
- Explicitly third-party tested for heavy metals — a meaningful safeguard for a resin extract
- Double Wood makes its COAs available on request and has built its reputation on testing transparency
- Clean single-active extract with no proprietary blend hiding the dose
- Standardises to total boswellic acids (65%), not a stated AKBA % — same precision gap as NOW
- 240-cap bottle is poor value if boswellia turns out not to help you — test with a smaller pack first
- No co-factors and a no-frills value-brand presentation
- You've already confirmed boswellia helps your joints and want a long-haul bulk supply
- You want a 1,000 mg, 65%-standardised daily dose in two capsules
- You value explicit third-party heavy-metal testing on a resin extract
- You want a long runway at a reasonable cost-per-dose (240 caps, ~4 months at the label's two-a-day dose)
- You're buying your first boswellia bottle — test with a smaller pack first (Swanson #5 or Nutricost #6)
- You want a named AKBA-enriched extract at its trial dose — get Life Extension Boswellia (#1)
- You want a complementary co-factor — NOW (#4) pairs the extract with turmeric
A Boswellia serrata extract standardised to 65% boswellic acids, delivering the full 1,000 mg/day trial dose across a two-capsule serving, in a 240-cap mega-bottle at a reasonable cost-per-serving, and notably third-party tested for heavy metals — a real safeguard for a resin extract. You trade AKBA precision (it standardises to total boswellic acids) and co-factors for a long-runway, tested, full-dose bulk supply. The right refill once you already know boswellia works for you — not the bottle to test it with.
Double Wood Boswellia answers a specific question: I've confirmed boswellia helps my joints — what's the best long-haul bulk supply? It's a full-strength standardised extract (1,000 mg per two-capsule serving at 65% boswellic acids, roughly 650 mg of acids per serving — 500 mg extract per cap) in a 240-capsule mega-bottle, at a reasonable cost-per-serving. The standout is testing: Double Wood explicitly third-party tests for heavy metals and microbial contaminants and makes its COAs available on request — a meaningful safeguard for a resin extract. The trade-offs are the familiar ones: it standardises to total boswellic acids rather than a stated AKBA %, it carries no co-factors, and the big bottle is poor value if boswellia turns out not to help you. This rounds out the list as the committed-user refill, not the first bottle. Here's the full breakdown.
The high-strength, heavy-metal-tested bulk refill once you know boswellia works.
Double Wood Boswellia is the sensible bulk-buy once you've confirmed boswellia helps your joints — a full-strength extract (1,000 mg per two-capsule serving at 65% boswellic acids) in a 240-cap mega-bottle at a reasonable cost-per-serving, and notably third-party tested for heavy metals, which matters for a resin extract. You give up AKBA precision (it standardises to total boswellic acids, not AKBA) and co-factors, but you keep a tested, full-dose, long-runway supply at a fair cost-per-dose. It rounds out the list rather than leading it, and the sequencing matters: don't make it your first bottle. Test boswellia with a smaller, cheaper pack first — Swanson (#5) or Nutricost (#6) — and once you know you respond, switch to Double Wood as the long-haul refill. Choose differently from the start if your priority is AKBA precision (Life Extension Boswellia #1), a complementary co-factor (NOW #4), or a clinician-grade clean label (Pure Encapsulations #3). For a committed user who wants a full-dose, heavy-metal-tested bulk supply, Double Wood is the right answer — two capsules a day, with or without food (label maximum four).
If This Doesn’t Fit — Try These
06Nutricost Boswellia Extract
Nutricost is the pure value play: a genuinely standardised 65%-boswellic-acid extract that hits the trial dose in two caps, at the lowest cost-per-gram on the list.
01Life Extension Boswellia
If you want a named, AKBA-enriched extract at exactly the dose it was tested at, this is the bottle.
05Swanson Boswellia
If you want to find out whether boswellia helps your joints without committing $15-25/month, Swanson is the right starting point — and crucially, it's a standardised extract, not the unstandardised resin that dominates the rest of the budget aisle.
Quick Answers
Is the heavy-metal testing actually meaningful for boswellia?
Yes — it's one of Double Wood's genuine differentiators. Boswellia is a resin extract, and plant-derived resins can carry heavy-metal contamination from soil and processing, so independent heavy-metal testing is a real safeguard rather than marketing fluff. Double Wood explicitly third-party tests for heavy metals and microbial contaminants and makes batch certificates of analysis available on request, which is more transparency than most boswellia bottles offer. For a botanical you'll take daily for months out of a 240-cap bottle, that testing is a sensible reassurance.
How many capsules a day, and how long does a bottle last?
Each 2-capsule serving is 1,000 mg of extract at 65% boswellic acids — roughly 650 mg of boswellic acids per serving (500 mg extract / about 325 mg acids per capsule). The label's suggested use is two capsules a day, which lands you right at the ~1,000 mg/day window Kimmatkar 2003 used (it's not recommended to exceed four capsules a day). At the label's suggested two-a-day dose, the 240-cap bottle lasts four months — one of the longer runways on the list, which is the whole point of the bulk format.
What do I give up versus the AKBA-enriched picks?
Precision on the most potent fraction. Like Nutricost and the other whole-extract picks, Double Wood standardises to total boswellic acids (65%) rather than a stated AKBA percentage — so it trails the AKBA-enriched tier (AprèsFlex in Life Extension, #1) on AKBA enrichment, the compound the strongest trial (Sengupta 2008) used at ~30% AKBA. What you keep is a high-strength 1,000 mg daily dose, heavy-metal-tested, in a long-runway bulk bottle. If you want to match the AKBA-enriched evidence exactly, get Life Extension Boswellia (#1); if you want a tested, full-dose bulk supply, this is it.
Should this be my first boswellia bottle?
Probably not. The 240-cap mega-bottle is good value per serving, but it's a poor first purchase: boswellia works for many people but not everyone, and a four-month supply is a lot to commit to before you know you respond. The smarter sequence is to test with a smaller, cheaper bottle first — Swanson (#5) or Nutricost (#6) — and once you've confirmed boswellia helps your joints, switch to Double Wood as the long-haul refill. It's the bulk-supply pick for committed users, not the test-the-supplement pick.
Is Double Wood a trustworthy brand?
Yes, for the value tier, and notably strong on testing transparency. Double Wood is a direct-to-consumer supplement brand that has built its reputation on third-party testing and makes batch COAs available on request — for this product, explicit heavy-metal and microbial testing, made in the USA. It isn't a clinician-grade marque like Pure Encapsulations, but its testing transparency is above average for the price, and for a botanical resin that heavy-metal verification is a meaningful and relevant safeguard. A reasonable quality floor well above unbranded bulk resin.
Who should NOT buy Double Wood?
Anyone buying their first boswellia bottle, or whose priority is AKBA precision or a co-factor. If you haven't confirmed boswellia works for you yet, start with a smaller bottle — Swanson (#5) or Nutricost (#6) — before committing to 240 caps. If you want a named AKBA-enriched extract at its trial dose, get Life Extension Boswellia (#1). If you want a complementary co-factor, NOW (#4) pairs the extract with turmeric. Double Wood is the bulk refill for committed users who want a full-dose, heavy-metal-tested supply at a reasonable cost-per-dose.
Sources & Further Reading
2 peer-reviewed sources, each linked to PubMed
- [1] Kimmatkar 2003 PMID 12622457 — Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee — a randomized double blind placebo controlled trial. Randomised, double-blind, placebo-controlled crossover trial in knee-osteoarthritis patients: a standardised Boswellia serrata extract significantly reduced knee pain, improved function, and increased walking distance versus placebo over 8 weeks. The efficacy and dosing basis (~333 mg three times daily, ~1,000 mg/day) for a standardised extract like Double Wood's.
- [2] Sengupta 2008 PMID 18667054 — A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Placebo-controlled trial of 5-Loxin (an AKBA-enriched Boswellia extract, ~30% AKBA) at 100 and 250 mg/day in knee osteoarthritis: significant, dose-related pain and function improvements, with benefits within ~7 days at 250 mg. Defines the AKBA-enriched precision tier Double Wood's total-boswellic-acid standardisation sits below.
Affiliate disclosure: every Amazon link uses our Associates tag (superachieverclub-20). We earn a small commission at no cost to you; it funds independent reviews. We never accept payment to change a ranking.